Pliant Therapeutics 

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$1.09-$1.95
Market Cap
$74.9M
Shares Short
3M

Financials

See more
Revenue (12 Mos)
$0
Revenue Growth (YoY)
-100%
Gross Profit (12 Mos)
$0
Diluted EPS
-$2.43

News

See more

Yahoo Finance • 13 days ago

Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095 in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting

Yahoo Finance • 5 months ago

Pliant Therapeutics Announces Interim Data from PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors

Yahoo Finance • 5 months ago

Pliant Therapeutics to Participate in the Piper Sandler Healthcare Conference

Yahoo Finance • 5 months ago

Idiopathic Pulmonary Fibrosis Research Report 2025-2035: Market Led by Roche, Pliant Therapeutics, Bristol-Myers Squibb, and Vicore as Next-Gen Antifibrotics and Targeted Therapies Drive Innovation

About

CEO
Dr. Bernard Coulie M.B.A., M.D., Ph.D.
Address
331 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
49